Catalyst Wire Dossier Catalyst Wire Dossier

ACT-453859

· Idorsia Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-453859, covering 2018-07-10 to 2018-07-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968) [Phase 1]

See pricing